Sexual dysfunction is a common disorder among women, especially during menopause. Metabolic syndrome is a multifactorial disease that, according to previous studies, there is a relationship between the metabolic syndrome and sexual dysfunction among women. The aim of this systematic review and meta-analysis is to obtain the prevalence of Female Sexual Dysfunction (FSD) among women with metabolic syndrome, and to analyze available related evidence.
Methods
In this systematic review and meta-analysis, the keywords of MeSH, female sexual dysfunction, FSD, metabolic syndrome were searched in PubMed, Web of Science, Scopus, Science Direct and Google Scholar. The searches were conducted without a lower time limit and until May 2022.
Results
The prevalence of FSD among women with metabolic syndrome was found to be 39.3% (95% CI: 28.3-51.5). In the subgroup analysis and in the review of 4 studies, the prevalence of sexual dysfunction in postmenopausal women with metabolic syndrome was 49.8% (95% CI: 26.1-73.6). Analyzing the results of the meta-regression test in examining the effect of the three factors of sample size, year of the study, age, and BMI of the patients on the heterogeneity of the meta-analysis, showed that with the increase of the sample size, the prevalence of sexual dysfunction among women with metabolic syndrome decreases (p < 0.05). Moreover, the prevalence of sexual dysfunction among women with metabolic syndrome increases (p < 0.05) with the increase in the years of conducting studies and the mean of age of women with metabolic syndrome. Also, with increasing mean of BMI of female patients with metabolic syndrome, the prevalence of sexual dysfunction in these women also increases (p < 0.05).
Conclusion
Female sexual dysfunction is a global health problem that can affect women's life to a great extent. Metabolic syndrome, which is a set of factors such as obesity, high blood pressure, and diabetes, affects sexual dysfunction in women. From this study, it can be concluded that there is a close relationship between metabolic syndrome and female sexual dysfunction.
sexual dysfunction women, metabolic syndrome female, menopause sexual health, female sexual function index, systematic review sexual dysfunction, meta-analysis sexual dysfunction, hypoactive sexual desire, arousal disorder women, insulin resistance sexual function, cardiovascular risk menopause
PMID 37975075 37975075 DOI 10.1007/s40200-023-01267-5 10.1007/s40200-023-01267-5
Cite this article
Salari, N., Moradi, M., Hosseinian-Far, A., Khodayari, Y., & Mohammadi, M. (2023). Global prevalence of sexual dysfunction among women with metabolic syndrome: a systematic review and meta-analysis. *Journal of diabetes and metabolic disorders*, *22*(2), 1011-1019. https://doi.org/10.1007/s40200-023-01267-5
Salari N, Moradi M, Hosseinian-Far A, Khodayari Y, Mohammadi M. Global prevalence of sexual dysfunction among women with metabolic syndrome: a systematic review and meta-analysis. J Diabetes Metab Disord. 2023;22(2):1011-1019. doi:10.1007/s40200-023-01267-5
Salari, N., et al. "Global prevalence of sexual dysfunction among women with metabolic syndrome: a systematic review and meta-analysis." *Journal of diabetes and metabolic disorders*, vol. 22, no. 2, 2023, pp. 1011-1019.
Chang CP et al., 2022Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
Treatment for gynecologic cancer is associated with sexual dysfunction, which may present during and/or after treatment. The aim of this study was to investigate the risk of sexual dysfunction among g...
Introduction: Women living with HIV (WLWH) experience accelerated ageing and an increased risk of age-associated diseases earlier in life, compared with women without HIV. This is likely due to a comb...
Menopause is an aging process and an important time equivalent to one-third of a woman's lifetime. Menopause significantly increases the risk of cardiometabolic diseases, such as obesity, type 2 diabe...